BridgeMD
New treatment option for Stroke
Official title Effects of tVNS and mCIMT in Chronic Stroke
ClinicalTrials.gov ID: NCT07272239
What this study is testing
- What it's testing
- Stroke is a leading cause of death and disability worldwide, resulting in significant physical and cognitive impairments. Arm weakness is most common after stroke and its treatment is recognized as an area of considerable need.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75
You may be able to join if
- Both male and female patients are included in the study.
- Left sided ischemic stroke patients.
- Patients with chronic, moderate-severe upper limb hemiparesis (\>6 months-2 years)
- Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS).
- Montreal Cognitive Assessment (MoCA) score ≥26.
You likely can't join if
- Participants who show the symptoms of global or receptive aphasia.
- Participants who have a history of significant neurological or psychiatric disorders, other than stroke, that could interfere with upper limb motor...
- Modified Ashworth scale score ≥ 3 of the affected upper extremity.
- Patients who are not able to sit with or without support.
- Patients with severe apraxia, somatosensory problems.
- Resting heart rate (\< 50 beats/min).
See the full eligibility criteria
- Both male and female patients are included in the study.
- Left sided ischemic stroke patients.
- Patients with chronic, moderate-severe upper limb hemiparesis (\>6 months-2 years)
- Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS).
- Montreal Cognitive Assessment (MoCA) score ≥26.
- Participants who show the symptoms of global or receptive aphasia.
- Participants who have a history of significant neurological or psychiatric disorders, other than stroke, that could interfere with upper limb motor or sensory recovery.
- Modified Ashworth scale score ≥ 3 of the affected upper extremity.
- Patients who are not able to sit with or without support.
- Patients with severe apraxia, somatosensory problems.
- Resting heart rate (\< 50 beats/min).
- Participants who are currently participating in another clinical trial or research study.
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.